<DOC>
	<DOC>NCT00749398</DOC>
	<brief_summary>This is a national, multi-center, observational, prospective photographic atlas study in subjects who are treated with infliximab for moderate-to-severe psoriasis in daily clinic according to local country regulations and reimbursement.</brief_summary>
	<brief_title>Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)</brief_title>
	<detailed_description>Subjects will enter this study using a non-probability sampling method.</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Male or female, age &gt;=18 with moderatetosevere psoriasis. Patient for whom the physician has decided to initiate psoriasis treatment with infliximab in accordance with the terms of the European labeling. Patient must demonstrate his/her willingness to participate in the observational study by signing a written consent. Patient unable to understand and answer a self administered questionnaire. No specific noninclusion criteria will be applied to eligible patients. Contradiction and/or Precaution listed in the Summary of Product Characteristics.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>